Timberlyne Therapeutics
San Diego, CA
Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs.
timberlyne-tx.comCompany Details
Founded
- 2024
Employees
- Between 10 - 50 employees
Raised
- $180,000,000
Headquarters Location
- San Diego, CA
Public
- No
Acquired
- No
CEO
Daniel Curran
Founders
- Siyu ShiChristian Fougner
Company Collections
These are collections Timberlyne Therapeutics is a part of. Click on the collection name to view similar companies.
Timberlyne Therapeutics' Industries
Timberlyne Therapeutics Headquarters Location
San Diego, CA 92134
Total Amount Raised: $180,000,000
Timberlyne Therapeutics Funding Rounds
Series A
$180,000,000
Series A Investors
AbingworthBain Capital Life Sciences FundVenrock Healthcare Capital Partners3H Health InvestmentLilly Asia VenturesBraidwellBoyu Capital
Funding info provided by Diffbot.
Timberlyne Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Timberlyne Therapeutics.